
Health Care Technology
Amsino Named Exclusive Flush Syringe Supplier For Mount Sinai Health System

POMONA, Calif., Nov. 13, 2025 /PRNewswire/ -- Amsino International, Inc. today announced a strategic agreement whereby Amsino will become the exclusive supplier of flush syringes to the Mount Sinai Health System.
Mount Sinai Health System Partnership
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area with seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. The System serves millions of patients annually across its vast network.
As part of this new exclusive supplier agreement, Amsino will provide Mount Sinai's hospitals, outpatient units, and procedural services with flush syringes in 3mL (37043US), 10mL sterile path (IVF1010TM), and 10mL sterile field ready (IVF1210SS) configurations to support critical care, medication administration, vascular access, and infusion practices.
North American Manufacturing Expansion: Strengthening Capacity & Resiliency
In support of increasing demand for pre-filled syringes and IV sets, Amsino recently completed the acquisition of MedXL to expand its existing North American manufacturing capabilities and increase prefilled syringe capacity to more than 500 million syringes annually.
This acquisition reflects Amsino's strategy to place critical medical manufacturing closer to major U.S. customers, thereby enhancing supply chain resilience and reducing the risk of allocations or backorders.
As Amsino's President of North America, Jeff Reid indicates "We are thrilled to support Mount Sinai at a time when supply reliability is more critical than ever. Our supply chain resilience model – backed by increased manufacturing muscle from the North American manufacturing acquisition – positions us to deliver on our promise of quality, continuity, and customer focus and is increasingly being validated by partnerships with leading hospital groups like Mount Sinai."
About Amsino International, Inc.
Amsino International is a medical device and consumables manufacturer focused on delivering healthcare solutions ranging from medication delivery and respiratory therapy to urological care and surgical supplies. Our mission is to provide safe, efficient, and high value products that support clinicians and patients. Amsino's latest manufacturing expansion further boosts its North American capabilities and strengthens supply chain resilience.
View original content to download multimedia:https://www.prnewswire.com/news-releases/amsino-named-exclusive-flush-syringe-supplier-for-mount-sinai-health-system-302614852.html
SOURCE Amsino International
Frequently Asked Questions
What products will Amsino provide to Mount Sinai?
Amsino will provide Mount Sinai with 3mL, 10mL sterile path, and 10mL sterile field ready flush syringes.
Why did Amsino expand its North American manufacturing?
To increase prefilled syringe capacity and enhance supply chain resilience for major U.S. customers.
What is Amsino's mission?
To provide safe, efficient, and high-value medical products that support clinicians and patients.
First published on Thu, Nov 13, 2025
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Protecting Print Fleets: Symphion Addresses Complacency In Printer Endpoint Protection With Two New Offerings
School Specialty LLC Announces Acquisition Of Nasco Education U.S.
Scowtt Raises $12M Series A To Transform Performance Marketing With AI-Powered Advertising Platform
Unified.To Powers 550% API Usage Growth In Six Months Amid Rising AI Adoption
Broadridge's Distributed Ledger Repo Platform Processes $368 Billion In Average Daily Trade Volumes In November
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.

Join The Discussion